Market Scope

Trusted Partner of Industry and Medical Professionals for Market Data, Independent Perspective, & Objective Analysis

Latest Reports Latest News

Market Scope Methodology

A Multi-Step Approach for Accurate & Timely Data

Proprietary data

  • 20+ years of physician survey data
  • Disease models
  • Cultivated database of physicians, ASCs, and hospitals
  • Insight from our team of in-house industry experts

Public data

  • Attendance and participation at major, worldwide meetings
  • Public health systems and registries
  • Clinical study data
  • Analysis of company-published financial reports

Physician Surveys

For 20+ years, we have surveyed physicians to provide both physicians & industry professionals unbiased insight into the market.

Complete a Survey

On average, our surveys take only 5 to 15 minutes to complete. Survey results help you analyze practice patterns, evaluate treatment choices, and benchmark your practice.

Benchmark Your Performance

Benchmark reports allow you to gauge your performance, track your practice metrics over time, and compare your practice to national averages.

View Market Insights & Analytics

Additional free data tools include instant survey results, weekly polls, PowerPoint charts, and more.

Learn More Register Today

Latest Market Reports

Market Scope's industry reports are meticulously prepared by a dedicated team of in-house consultants/analysts with over 100 years of collective experience.

Latest Industry News & Trends

Apellis Raises $404.2 Million in Public Offering

Apellis Pharmaceuticals, now of Waltham, Massachusetts, announced Jan. 14 that it had raised $404.2 million in gross proceeds from an underwritten public offering of common stock, including the ful...

BreakingGene TherapyOphthalmicRegulationRetina
FDA Lifts Clinical Hold on Regenxbio’s Gene Therapy Candidate for Wet AMD

Gene therapy company Regenxbio reported Jan. 9 that the FDA has removed a partial clinical hold on its Phase I/IIa trial of subretinal delivery of RGX-314 for wet age-related macular degeneration w...

STAAR Gains Supplemental Lens Approval for EVO Visian ICL in Post-Cataract Patients

STAAR Surgical has gained CE marking for use of its implantable collamer lenses (ICL) as a supplemental or “piggyback” lens in post-cataract surgery patients, the company announced Jan. 13. A suppl...

Exonate Teams with Janssen to Develop Eye Drop for Wet AMD, DME

Exonate, of Cambridge, England, has entered into a strategic collaboration agreement with Janssen Pharmaceuticals to develop an eye drop treatment for retinal vascular diseases, the company announc...

CPT Codes Established for Home OCT Use

The American Medical Association’s Current Procedural Terminology (CPT) panel has established three new Category III codes (0604T, 0605T, 0606T) to report patient-initiated remote retinal optical c...

Medtronic Issues Field Safety Notice for Mazor X Positioner

Medtronic issued a field safety notice Jan. 7 for its Mazor X surgical system with Positioner Type II latching device. The positioner, which locks onto the OR table through a pneumatic system, may ...

Exactech Names Johnson New CEO

Exactech, a Florida-based orthopedic implant company with solutions for extremities, knees, and hips, announced Jan. 7 that Darin Johnson will be taking David Petty’s place as president and CEO. Pe...

Coherus Acquires Commercial Rights for Avastin Biosimilar in the US

Coherus BioSciences has entered into a licensing agreement with Innovent Biologics of China to commercialize Innovent’s biosimilar candidate to Avastin (bevacizumab) in the US and Canada, the compa...

Join Market Scope Today

Register A Corporate Account

A corporate accounts gives you access to licensed reports and subscriptions, the latest news, and a personalized dashboard.

Select one or more
Select one or more

Register A Clinical Account

A clinical account gives you access to survey participation and results, weekly polls, benchmark reports, a searchable news archive, and more on a personalized dashboard.

US Surveys
May select more than one
Outside of US Surveys

Market Scope

13421 Manchester Road, Suite 201 | St. Louis, MO 63131 | Phone: 314-835-0600 | Email:

©2020 Market Scope, LLC. All Rights reserved.